Call for Abstract
Scientific Program
31st World Conference on Gastroenterology & Hepatology, will be organized around the theme “Theme : Emerging Trends in Hepatology: Liver Disease, Cirrhosis, and Transplantation”
Gastroenterology-2025 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Gastroenterology-2025
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
This session explores AI-assisted and robotic endoscopy, capsule endoscopy, and enhanced imaging techniques for early disease detection and treatment precision. Benefits: Participants gain knowledge of cutting-edge endoscopic procedures, improved diagnostic accuracy, and exposure to advanced imaging technologies.
Covers the role of the gut microbiome in gastrointestinal diseases, including microbiome-targeted therapies, probiotics, and dietary interventions. Benefits: Attendees will understand how gut microbiota influences health, emerging microbiome-based treatments, and their clinical applications in various GI disorders.
Discusses the growing burden of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), along with metabolic factors, novel diagnostics, and pharmacological advancements. Benefits: Participants gain insights into treatment guidelines, emerging drugs, and lifestyle interventions to manage fatty liver diseases effectively.
Explores AI-driven diagnostics, machine learning applications in endoscopy, and predictive analytics for personalized treatment approaches. Benefits: This session provides an understanding of AI integration in clinical practice, improved patient outcomes, and the future of AI in gastroenterology
Reviews novel biologics, JAK inhibitors, and gut-targeted therapies for Crohn’s disease and ulcerative colitis. Benefits: Delegates learn about innovative treatment strategies, optimizing personalized IBD management, and the latest research findings in the field
Discusses organ preservation techniques, donor selection, and immunosuppressive protocols to improve transplant success. Benefits: Attendees understand evolving transplantation methodologies, reduced rejection risk, and long-term patient care advancements.
Explores biomarker-driven personalized therapies for liver diseases, allowing targeted treatment strategies. Benefits: Participants gain insights into precision medicine applications, patient-specific therapeutic approaches, and future trends in hepatology
Covers liquid biopsies, AI-based screening, and preventive strategies for GI malignancies. Benefits: Attendees improve their knowledge of early cancer detection methods, innovative screening tools, and advancements in oncological care.
Discusses fecal microbiota transplantation (FMT) and engineered microbiota for gut disorders. Benefits: Clinicians and researchers explore novel microbiome-based treatments and their clinical applications
Focuses on the latest developments in treating pancreatitis and pancreatic cancer. Benefits: Participants gain a deeper understanding of risk factors, diagnostic tools, and evolving therapies.
Explores new antiviral treatments and global hepatitis elimination strategies. Benefits: Attendees gain awareness of curative therapies and updated treatment guidelines for hepatitis B and C
Reviews IBS, gastroparesis, and gut-brain axis interactions. Benefits: Delegates learn about the latest advancements in treating functional gastrointestinal disorders.
Discusses congenital liver disorders, pediatric IBD, and metabolic conditions in children. Benefits: Specialists gain insights into unique pediatric GI conditions and treatment innovations.
Covers non-surgical weight-loss procedures, including endoscopic sleeve gastroplasty. Benefits: Attendees learn about endoscopic interventions for obesity and metabolic disorder management.
Explores dietary approaches to liver disease prevention and treatment. Benefits: Participants understand personalized nutrition strategies for managing liver conditions.
Reviews non-invasive monitoring techniques and therapeutic approaches. Benefits: Delegates gain knowledge of the latest treatment strategies for cirrhosis and its complications.
Discusses advancements in endoscopic hemostasis techniques. Benefits: Attendees gain hands-on exposure to emergency endoscopy and bleeding management protocols
Explores digestive health concerns emerging after COVID-19. Benefits: Participants understand the long-term impact of COVID-19 on the digestive system and updated management strategies.
Covers checkpoint inhibitors, CAR-T cell therapies, and targeted oncology treatments. Benefits: Delegates gain a comprehensive understanding of immunotherapy breakthroughs and personalized cancer treatment approaches.
Discusses the latest biomarkers for early disease detection and treatment response monitoring. Benefits: Attendees understand how biomarkers are transforming diagnostics, improving precision medicine, and optimizing treatment outcomes.